Eikon Therapeutics Inc. (EIKN)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.1
Day's range
$15.71

Eikon Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 4.99 M $65.17 M   30.16% 9.22%
BLACKROCK, INC. 08/07/2026 4.28 M $55.87 M   28.98% 7.91%
FORESITE CAPITAL MANAGEMENT IV, LLC 08/14/2026 1.94 M $25.37 M   0.00% 3.59%
MERCK & CO., INC. 08/07/2026 1.67 M $21.75 M   0.00% 3.08%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 1.60 M $20.82 M   30.49% 2.95%
FORESITE CAPITAL MANAGEMENT V, LLC 08/14/2026 1.32 M $17.21 M   0.00% 2.44%
CAPITAL WORLD INVESTORS 08/12/2026 1.18 M $15.35 M   2.82% 2.17%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.01 M $13.12 M   2.99% 1.86%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 922.71 K $12.04 M   -4.82% 1.70%
ECOR1 CAPITAL, LLC 08/14/2026 732.61 K $9.56 M   0.00% 1.35%
ALLIANCEBERNSTEIN L.P. 08/14/2026 641.89 K $6.79 M   -37.20% 1.19%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 556.96 K $7.27 M   103.32% 1.03%
BAKER BROS. ADVISORS LP 08/14/2026 555.56 K $7.25 M   0.00% 1.03%
SOROS CAPITAL MANAGEMENT LLC 08/14/2026 484.67 K $6.32 M   0.00% 0.90%
STEPSTONE GROUP LP 08/13/2026 395.34 K $5.16 M   0.00% 0.73%
CANADA PENSION PLAN INVESTMENT BOARD 08/14/2026 379.02 K $4.95 M   0.00% 0.70%
STATE STREET CORP 09/22/2026 354.09 K $4.62 M   781.93% 0.65%
FRANKLIN RESOURCES INC 08/13/2026 350.00 K $4.57 M   0.00% 0.65%
GENERAL CATALYST GROUP MANAGEMENT, LLC 08/17/2026 305.23 K $3.98 M   0.00% 0.56%
UBS GROUP AG 08/13/2026 263.93 K $3.44 M   165.50% 0.49%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2026 256.05 K $3.34 M   100.00% 0.47%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 182.11 K $2.38 M   38.93% 0.34%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 182.11 K $2.38 M   100.00% 0.34%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 179.78 K $2.35 M   100.00% 0.33%
NORTHERN TRUST CORP 08/13/2026 175.93 K $2.30 M   286.39% 0.32%
ENSIGN PEAK ADVISORS, INC 08/14/2026 170.49 K $2.22 M   -14.76% 0.31%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 148.90 K $1.94 M   993.77% 0.28%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 148.41 K $1.94 M   12.47% 0.27%
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 08/13/2026 134.50 K $1.76 M   -4.17% 0.25%
MILLENNIUM MANAGEMENT LLC 08/14/2026 133.02 K $1.74 M   -24.26% 0.25%
COMPREHENSIVE FINANCIAL MANAGEMENT LLC 08/14/2026 116.28 K $1.52 M   0.00% 0.21%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 115.00 K $1.50 M   0.00% 0.21%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 98.00 K $1.28 M   100.00% 0.18%
TD ASSET MANAGEMENT INC 08/04/2026 57.07 K $744.82 K   0.00% 0.11%
ALPS ADVISORS INC 07/29/2026 54.95 K $717.07 K   100.00% 0.10%
INVESCO LTD. 08/14/2026 50.90 K $664.25 K   100.00% 0.09%
BANK OF NEW YORK MELLON CORP 08/06/2026 47.79 K $623.63 K   100.00% 0.09%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 37.90 K $494.62 K   100.00% 0.07%
BANK OF AMERICA CORP /DE/ 08/14/2026 37.58 K $490.35 K   -56.38% 0.07%
POLEN CAPITAL MANAGEMENT LLC 08/04/2026 35.74 K $466.43 K   100.00% 0.07%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 09/09/2026 35.36 K $461.41 K   23.53% 0.07%
PROSHARE ADVISORS LLC 08/11/2026 29.69 K $387.39 K   100.00% 0.05%
NUVEEN, LLC 08/11/2026 28.99 K $378.29 K   100.00% 0.05%
XTX TOPCO LTD 08/14/2026 27.46 K $358.29 K   5.37% 0.05%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 26.80 K $349.70 K   100.00% 0.05%
RHUMBLINE ADVISERS 08/12/2026 24.48 K $319.50 K   100.00% 0.05%
DEUTSCHE BANK AG\ 08/07/2026 21.52 K $280.86 K   100.00% 0.04%
WELLS FARGO & COMPANY/MN 08/14/2026 19.35 K $252.49 K   100.00% 0.04%
JUMP FINANCIAL, LLC 08/13/2026 18.07 K $235.80 K   100.00% 0.03%
CITIGROUP INC 08/03/2026 16.78 K $218.97 K   100.00% 0.03%

Eikon Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 90 institutional investors and hedge funds held shares of Eikon Therapeutics Inc.. The most heavily invested institutionals were:

FMR LLC: 4.99 M

BlackRock, Inc.: 4.28 M

Foresite Capital Management IV, LLC: 1.94 M

Merck & Co., Inc.: 1.67 M

T. Rowe Price Investment Management, Inc.: 1.6 M

Foresite Capital Management V, LLC: 1.32 M

49.26% of Eikon Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 26.67 M shares in the last 24 months. This purchase volume represents approximately $397.69 M in transactions.